US BANCORP \DE\ - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 50 filers reported holding REDHILL BIOPHARMA LTD in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q3 2022$0
-100.0%
7020.0%0.00%
Q2 2022$1,000
-50.0%
7020.0%0.00%
Q1 2022$2,0000.0%7020.0%0.00%
Q4 2021$2,000
-33.3%
7020.0%0.00%
Q3 2021$3,000
+200.0%
702
+312.9%
0.00%
Q4 2020$1,0000.0%170
+56.0%
0.00%
Q3 2020$1,0001090.00%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Ibex Investors LLC 527,000$4,653,0002.58%
683 Capital Management, LLC 3,631,019$32,062,0002.08%
CVI Holdings, LLC 22,367$198,0000.33%
MENTA CAPITAL LLC 85,785$757,0000.26%
MENORA MIVTACHIM HOLDINGS LTD. 421,000$3,717,0000.10%
Kepos Capital LP 218,800$1,932,0000.10%
Claret Asset Management Corp 47,522$420,0000.08%
Migdal Insurance & Financial Holdings Ltd. 389,914$3,443,0000.07%
Clear Harbor Asset Management, LLC 38,806$323,0000.06%
Orbimed Advisors 284,900$2,516,0000.03%
View complete list of REDHILL BIOPHARMA LTD shareholders